Press release
Psoriatic Arthritis Pipeline, FDA Approvals, Clinical Trials Assessment and Companies | Mylan, Celltrion, Fresenius Kabi, Pfizer, Fujifilm Kyowa Kirin Biologics, Amgen, Zydus cedilla, Sandoz, and others.
Psoriatic Arthritis Pipeline
Key Takeaways from the Psoriatic Arthritis Pipeline Report
• DelveInsight's Psoriatic Arthritis pipeline report depicts a robust space with 50+ Psoriatic Arthritis companies working to develop 50+ pipeline therapies for Psoriatic Arthritis treatment.
• The leading companies working in the Psoriatic Arthritis Market include Mylan, Celltrion, Fresenius Kabi, Pfizer, Fujifilm Kyowa Kirin Biologics, Amgen, Zydus cedilla, Sandoz, Shanghai Henlius Biotech, Hetero Biopharma, CinnaGen, Fresenius Kabi, Torrent Pharmaceuticals, Cipla, Biogen, AbbVie, Biocad, Boehringer Ingelheim, Sun Pharma Global, Gilead Sciences, UCB Biopharma, Formycon, Bristol-Myers Squibb, AbGenomics, Boehringer Ingelheim, Affibody, AltruBio, Bio-Thera Solutions, Dong-A ST, Synact Pharma, NeuClone, 3SBio, Qyuns Therapeutics, Kangpu Biopharmaceuticals, Alpine Immune Sciences, Akeso Biopharma, Polpharma Biologics, Avotres, Bio-Thera Solutions, Xbrane Biopharma, XBiotech, Innovimmune Biotherapeutics, Aclaris Therapeutics, Luye Pharma Group, Evelo, Levolta Pharmaceuticals, DNX Biopharmaceuticals, Mycenax Biotech, and others.
• Promising Psoriatic Arthritis Pipeline Therapies in the various stages of development include NDI-034858, Alefacept, Methotrexate, Etanercept, UCB4940 40 mg, Methotrexate (MTX), and others.
• January 2024: UCB Biopharma SRL announced a study of Phase 3 clinical trials for Bimekizumab. This is a study to assess the long-term safety, long-term efficacy and tolerability of bimekizumab administered subcutaneously (sc) in adult subjects with psoriatic arthritis (PsA).
• January 2024: Novartis Pharmaceuticals announced a study of Phase 3 clinical trials for AIN457. Optional open label, roll over extension study to investigate the efficacy and safety of secukinumab treatment in Juvenile Idiopathic Arthritis (JIA) subtypes of Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA).
• September 2023: ACELYRIN Inc. announced a study of phase 2 & 3 clinical trials for Izokibep. Izokibep is a potent and selective inhibitor of interleukin (IL)-17A that is being developed for treatment of psoriatic arthritis (PsA). This study will evaluate the efficacy of izokibep in subjects with PsA.
• September 2023: Novartis Pharmaceuticals announced a study of phase 3 clinical trials for Secukinumab and Ustekinumab. The purpose of this study is to compare the safety and efficacy of secukinumab and ustekinumab in patients with active psoriatic arthritis who showed failure to previous TNFα-inhibitor treatment.
Request a sample and discover the recent advances in Psoriatic Arthritis Treatment Drugs @ Psoriatic Arthritis Pipeline Report- https://www.delveinsight.com/report-store/psoriatic-arthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
In the Psoriatic Arthritis pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Psoriatic Arthritis collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Psoriatic Arthritis Overview
Psoriatic Arthritis is a chronic inflammatory disease of the joints that can be associated with the psoriasis. It can affect both peripheral joints and axial skeleton causing pain, stiffness, swelling and joint destruction. This joint pathology develops gradually and cause more nuisance than disabling. Psoriatic arthritis is considered as seronegative spondyloarthropathies.
Find out more about Psoriatic Arthritis Therapeutics Assessment @ Psoriatic Arthritis Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/psoriatic-arthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Psoriatic Arthritis Emerging Drugs Profile
• ABT-494: AbbVie
• Risankizumab: Abbvie
Psoriatic Arthritis Pipeline Therapeutics Assessment
There are approx. 50+ key companies which are developing the Psoriatic Arthritis therapies. The Psoriatic Arthritis companies which have their Psoriatic Arthritis drug candidates in the most advanced stage, i.e. Registered include, Abbvie.
Learn more about the emerging Psoriatic Arthritis Pipeline Therapies @ Psoriatic Arthritis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/psoriatic-arthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Psoriatic Arthritis Pipeline Report
• Coverage- Global
• Psoriatic Arthritis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Psoriatic ArthritisTherapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Psoriatic Arthritis Companies- Mylan, Celltrion, Fresenius Kabi, Pfizer, Fujifilm Kyowa Kirin Biologics, Amgen, Zydus cedilla, Sandoz, Shanghai Henlius Biotech, Hetero Biopharma, CinnaGen, Fresenius Kabi, Torrent Pharmaceuticals, Cipla, Biogen, AbbVie, Biocad, Boehringer Ingelheim, Sun Pharma Global, Gilead Sciences, UCB Biopharma, Formycon, Bristol-Myers Squibb, AbGenomics, Boehringer Ingelheim, Affibody, AltruBio, Bio-Thera Solutions, Dong-A ST, Synact Pharma, NeuClone, 3SBio, Qyuns Therapeutics, Kangpu Biopharmaceuticals, Alpine Immune Sciences, Akeso Biopharma, Polpharma Biologics, Avotres, Bio-Thera Solutions, Xbrane Biopharma, XBiotech, Innovimmune Biotherapeutics, Aclaris Therapeutics, Luye Pharma Group, Evelo, Levolta Pharmaceuticals, DNX Biopharmaceuticals, Mycenax Biotech, and others.
• Psoriatic Arthritis Pipeline Therapies- NDI-034858, Alefacept, Methotrexate, Etanercept, UCB4940 40 mg, Methotrexate (MTX), and others.
Dive deep into rich insights for new drugs for Psoriatic Arthritis Treatment, Visit @ Psoriatic Arthritis Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/psoriatic-arthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Psoriatic Arthritis: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Psoriatic Arthritis- DelveInsight's Analytical Perspective
7. In-depth Commercial Assessment
8. Psoriatic Arthritis Collaboration Deals
9. Late Stage Products (Registered/Launch)
10. MYL-1401A: Mylan
11. Drug profiles in the detailed report…..
12. Late Stage Products (Registered)
13. ABT-494: AbbVie
14. Drug profiles in the detailed report…..
15. Late Stage Products (Preregistration)
16. Tildrakizumab: Sun Pharma Global
17. Drug profiles in the detailed report…..
18. Late Stage Products (Phase III)
19. Filgotinib: Gilead Sciences
20. Drug profiles in the detailed report…..
21. Mid Stage Products (Phase II)
22. PF-06700841: Pfizer
23. Drug profiles in the detailed report…..
24. Early Stage Products (Phase I)
25. BAT2506: Bio-Thera Solutions
26. Drug profiles in the detailed report…..
27. IND Stage Products
28. KPG-612: Kangpu Biopharmaceuticals
29. Drug profiles in the detailed report…..
30. Preclinical Stage Products
31. ALPN 101: Alpine Immune Sciences
32. Drug profiles in the detailed report…..
33. Discovery Stage Products
34. DNX 514: DNX Biopharmaceuticals
35. Inactive Products
36. Psoriatic Arthritis Key Companies
37. Psoriatic Arthritis Key Products
38. Psoriatic Arthritis- Unmet Needs
39. Psoriatic Arthritis- Market Drivers and Barriers
40. Psoriatic Arthritis- Future Perspectives and Conclusion
41. Psoriatic Arthritis Analyst Views
42. Psoriatic Arthritis Key Companies
43. Appendix
For further information on the Psoriatic Arthritis Pipeline therapeutics, reach out to Psoriatic Arthritis Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/psoriatic-arthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Important Published Links
https://biomolecula.ru/authors/25303
https://discuss.machform.com/u/dennydones9191
https://dagshub.com/dennydones9191
https://careerkarma.com/profile/clr7d7z0c04v2lf3k5lrx9vyr/
https://gotech.mn.co/posts/48477911
https://landmarknew.mn.co/posts/48477947
https://infiniteabundance.mn.co/posts/48478016
https://wellbeingmatters.mn.co/posts/48478424
https://vrjam.mn.co/posts/48478544
https://decidim.santcugat.cat/profiles/dennydones9/activity
https://haveagood.holiday/users/336105
https://participa.rubi.cat/profiles/dennydones9191/activity
https://forum.callofwar.com/index.php?user/60304-dennydones9191/#about
https://dbook.mn.co/posts/48401881
https://lxgonline.mn.co/posts/navigating-the-landscape-of-hypertriglyceridemia-market-current-trends-and-future-prospects
https://www.penname.me/@dennydones99
https://community.fyers.in/member/7Yldtdsvui
https://spurstartup.mn.co/posts/48406045
https://pressurecooker.mn.co/posts/48406225
https://regenerative-future.mn.co/posts/navigating-the-hypertriglyceridemia-market-innovations-and-challenges
https://commiss.io/dennydones
https://www.pledgeme.co.nz/profiles/221820/
https://brave-comfort.mn.co/posts/48409148
https://gamebook.mn.co/posts/navigating-the-landscape-of-the-hypertriglyceridemia-market
https://kktix.com/user/5068280
https://network-373.mn.co/posts/48353213
https://body-imagine.mn.co/posts/48353364
https://pimpmyairgun.mn.co/posts/48353478
https://gtribe.mn.co/posts/advancements-and-opportunities-in-the-vulvar-cancer-market
https://communenour.mn.co/posts/emerging-trends-and-market-dynamics-in-vulvar-cancer-treatment
https://synkretic.mn.co/posts/understanding-the-vulvar-cancer-market-trends-challenges-and-innovations
https://jlfa2020.mn.co/members/16644457
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/graves-disease-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriatic Arthritis Pipeline, FDA Approvals, Clinical Trials Assessment and Companies | Mylan, Celltrion, Fresenius Kabi, Pfizer, Fujifilm Kyowa Kirin Biologics, Amgen, Zydus cedilla, Sandoz, and others. here
News-ID: 3347481 • Views: …
More Releases from DelveInsight Business Research LLP
Gene Therapies for Cardiomyopathies Market to Witness Growth by 2032 | Adverum B …
DelveInsight's "Gene Therapies for Cardiomyopathies Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Gene Therapies for Cardiomyopathies, historical and forecasted epidemiology as well as the Gene Therapies for Cardiomyopathies market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Gene Therapies for Cardiomyopathies market report provides current treatment practices, emerging drugs, Gene Therapies for Cardiomyopathies market share of the…
Chronic Fatigue Syndrome Market to Witness Growth by 2032 | AIM Immunotech, Cort …
DelveInsight's "Chronic Fatigue Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Fatigue Syndrome, historical and forecasted epidemiology as well as the Chronic Fatigue Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Chronic Fatigue Syndrome market report provides current treatment practices, emerging drugs, Chronic Fatigue Syndrome market share of the individual therapies, and current and…
Cognitive Impairment Associated with Schizophrenia Market to Witness Growth by 2 …
DelveInsight's "Cognitive Impairment Associated with Schizophrenia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Cognitive Impairment Associated with Schizophrenia, historical and forecasted epidemiology as well as the Cognitive Impairment Associated with Schizophrenia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Cognitive Impairment Associated with Schizophrenia market report provides current treatment practices, emerging drugs, Cognitive Impairment Associated with…
Spinocerebellar Ataxias Market to Witness Growth by 2032 | Seelos Therapeutics I …
DelveInsight's "Spinocerebellar Ataxias Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Spinocerebellar Ataxias, historical and forecasted epidemiology as well as the Spinocerebellar Ataxias market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Spinocerebellar Ataxias market report provides current treatment practices, emerging drugs, Spinocerebellar Ataxias market share of the individual therapies, and current and forecasted Spinocerebellar Ataxias market size…
More Releases for Arthritis
Canine Arthritis Treatment Market to 2028 |Dechra Pharmaceuticals PLC, Canine Ar …
Market Research Hub (MRH) has carefully analyzed this research study titled Canine Arthritis Treatment Market: Asia Pacific Excluding Japan to Register the Fastest Growth During the Forecast Period: Global Industry Analysis (2013-2017) and Opportunity Assessment (2018-2028), which is available on its online portal. The aim of this assessment is to highlight the various projections expected to occur in the global market for Canine Arthritis Treatment. Readers can gain knowledge related…
Arthritis Consumer Experts launches JointHealth™ Education Advanced Therapies …
June 21, 2018
For Immediate Release
ACE launches JointHealth™ Education Advanced Therapies
North America’s first course designed to educate arthritis patients introduces new lesson on advanced therapies for inflammatory arthritis
(VANCOUVER) — Arthritis Consumer Experts (ACE) announced the launch of its newest on-line patient education course: JointHealth™ Education Advanced Therapies for Inflammatory Arthritis. This three-lesson course is designed to help patients living with inflammatory arthritis identify when the appropriate time to transition from conventional…
Rheumatoid Arthritis Drug Market Rheumatoid Arthritis Clinical Pipeline Report 2 …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Antirheumatoids: Call of Rheumatoid Arthritis
1.1 Prologue towards Rheumatoid Arthritis
1.2 Obtainable Treatment for Rheumatoid Arthritis
Molecular Mechanism of Antirheumatoids
2.1 Purpose of DMARDs in Rheumatoid Arthritis
2.2 Role of Biological Agents in Rheumatoid Arthritis
2.2.1 TNF- Inhibitors
2.2.2 Interleukin -1 and IL-6 Blockers
Classification of Rheumatoid Arthritis Drugs
3.1…
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the…
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the…
Worldwide Arthritis - EpiCast Report: Rheumatoid Arthritis - Epidemiology Foreca …
"EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
Description-
** Summary
Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the bodys immune system attacks the lining of the joints, known as…
